DMED — Diagnamed Holdings Balance Sheet
0.000.00%
Last trade - 00:00- CA$7.10m
- CA$6.91m
Annual balance sheet for Diagnamed Holdings, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 2.36 | 1.57 | 0.607 | 0.162 | 0.184 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.032 | 0.045 | 0.055 | 0.032 | 0.018 |
| Prepaid Expenses | |||||
| Total Current Assets | 2.39 | 1.62 | 0.662 | 0.202 | 0.216 |
| Total Assets | 2.39 | 1.62 | 0.662 | 0.202 | 0.216 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 0.15 | 0.37 | 0.426 | 0.467 | 0.666 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.15 | 0.37 | 0.426 | 0.467 | 0.666 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 2.24 | 1.25 | 0.236 | -0.265 | -0.45 |
| Total Liabilities & Shareholders' Equity | 2.39 | 1.62 | 0.662 | 0.202 | 0.216 |
| Total Common Shares Outstanding |